Health equity necessitates the inclusion of gender identity data in COVID-19 clinical trials.

Babu, Tara M; Wald, Anna; Restar, Arjee J.

Babu TM; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle; Department of Behavioral and Social Sciences, Yale University School of Public Health, New Haven, CT. Electronic address: Tbabu2@uw.edu.
Wald A; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle; Department of Laboratory Medicine and Pathology, University of Washington, Seattle; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Epidemiology, School of Public Health, University of Washington, Seattle; Department of Behavioral and Social Sciences, Yale University School of Public Health, New Haven, CT.
Restar AJ; Department of Epidemiology, School of Public Health, University of Washington, Seattle; Department of Behavioral and Social Sciences, Yale University School of Public Health, New Haven, CT.

Ann Epidemiol ; 85: 3-5, 2023 Sep.

Article en En | MEDLINE | ID: mdl-37391114